FGFR1 and breast carcinoma: It is important to note that breast cancer cells also use the Jagged1/Notch pathway to promote bone metastases (105), thus a focus on FGFR-1 expression in breast cancer bone metastases could unveil new answers in drug resistance mechanisms.